-
1.
公开(公告)号:US20100286152A1
公开(公告)日:2010-11-11
申请号:US12602829
申请日:2008-06-05
申请人: Giovanni Bernasconi , Steven Mark Bromidge , Andrew James Carpenter , Lucilla D'Adamo , Romano Di Fabio , Sebastien Guery , Francesca Pavone , Alfonso Pozzan , Marilisa Rinaldi , Fabio Maria Sabbatini , Yves St-Denis
发明人: Giovanni Bernasconi , Steven Mark Bromidge , Andrew James Carpenter , Lucilla D'Adamo , Romano Di Fabio , Sebastien Guery , Francesca Pavone , Alfonso Pozzan , Marilisa Rinaldi , Fabio Maria Sabbatini , Yves St-Denis
IPC分类号: A61K31/495 , C07D409/06 , C07D405/06 , C07D295/13 , C07D401/06 , C07D403/06 , C07D211/28 , A61K31/496 , A61K31/4525 , A61K31/445 , A61K31/506 , A61P3/00
CPC分类号: C07D333/76 , C07D211/34 , C07D213/56 , C07D213/61 , C07D239/26 , C07D295/15 , C07D307/81 , C07D307/85 , C07D307/91 , C07D317/46 , C07D317/60 , C07D319/18 , C07D333/60 , C07D405/06 , C07D471/04 , C07D487/04
摘要: The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof,
摘要翻译: 本发明涉及新的式(I)化合物或其药学上可接受的盐或溶剂合物,
-
2.Condensed N-Heterocyclic Compounds and their Use as CRF Receptor Antagonists 审中-公开
标题翻译: 浓缩N-杂环化合物及其作为CRF受体拮抗剂的用途公开(公告)号:US20110172255A1
公开(公告)日:2011-07-14
申请号:US11931313
申请日:2007-10-31
申请人: Daniele Andreotti , Giovanni Bernasconi , Emiliano Castiglioni , Stefania Anne Contini , Romano Di Fabio , Elettra Fazzolari , Aldo Feriani , Gabriella Gentile , Mario Mattioli , Anna Mingardi , Fabio Maria Sabbatini , Yves St-Denis
发明人: Daniele Andreotti , Giovanni Bernasconi , Emiliano Castiglioni , Stefania Anne Contini , Romano Di Fabio , Elettra Fazzolari , Aldo Feriani , Gabriella Gentile , Mario Mattioli , Anna Mingardi , Fabio Maria Sabbatini , Yves St-Denis
IPC分类号: A61K31/519 , C07D487/04 , C07D471/04 , A61K31/437 , A61P25/24 , A61P25/22
CPC分类号: C07D471/04 , C07D487/04
摘要: The present invention provides compounds of formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions mediated by corticotropin-releasing factor (CRF).
摘要翻译: 本发明提供式(I)化合物,其制备方法,含有它们的药物组合物及其在治疗由促肾上腺皮质激素释放因子(CRF)介导的病症中的用途。
-